Isosorbide-2-carbamate esters: Potent and selective butyrylcholinesterase inhibitors

Ciaran G. Carolan, Gerald P. Dillon, Joanne M. Gaynor, Sean Reidy, Sheila A. Ryder, Denise Khan, Juan F. Marquez, John F. Gilmer

Research output: Contribution to journalArticlepeer-review

34 Citations (Scopus)

Abstract

In this study, we report the SAR and characterization of two groups of isosorbide-based cholinesterase inhibitors. The first was based directly on the clinically used nitrate isosorbide mononitrate (ISMN) retention of the 5-nitrate group and introduction of a series of 2-carbamate functionalities. The compounds proved to be potent and selective inhibitors of human plasma butyrylcholinesterase (huBuChE). In the second group, the nitrate ester was removed and replaced with a variety of alkyl and aryl esters. These generally exhibited nanomolar potency with high selectivity for BuChE over acetylcholinesterase (AChE). The most potent and selective compound was isosorbide-2-benzyl carbamate-5-benzoate with an IC50 of 4.3 nM for BuChE and > 50000 fold selectivity over human erythrocyte AChE. Inhibition with these compounds is time-dependent, competitive, and slowly reversible, indicating active site carbamylation.

Original languageEnglish
Pages (from-to)6400-6409
Number of pages10
JournalJournal of Medicinal Chemistry
Volume51
Issue number20
DOIs
Publication statusPublished - 23 Oct 2008

Fingerprint

Dive into the research topics of 'Isosorbide-2-carbamate esters: Potent and selective butyrylcholinesterase inhibitors'. Together they form a unique fingerprint.

Cite this